Welcome to the web-presentation of
K-BIO Institute for Cellbiotechnology and Immunology GmbH
Leader in immunological research and development(R&D) of active autologous cancer immunotherapy AHICE, and for after-care, as also against auto-immune-diseases, and for prevention as well, by means of use the complex totality of autologous synthesised, human immune response working substances, targeted selective against the recognized altered body cells pathologically - won out of patients own blood.
PRODUCTS AND SERVICES
Product 1
Active autologous cancer immunotherapy, autologous cancer vaccine AHICE, targeted against
♦ differentiated body-cells pathologically (e.g. cancer, auto-immune diseases etc.) basically,
♦ for cancer-after-care, and for
♦ prevention.
Special case 2
immunotherapy ahice of peritoneal-cancer
Special case 3
Immunotherapy AHICE of Colon Cancer
Special case 4
Immunotherapy AHICE of Pancreas Cancer
Special case 5
Immunotherapy of Breast Cancer
a. o.
back → Home, Language next → Autologous Vaccine AHICE